The Author(s), under exclusive licence to The Royal College of Ophthalmologists. Ozurdex ® could be reasonably proposed as first-line treatment, at least when MO occurs following PFCL-assisted drainage, given the favourable long-term benefit/risk ratio. Degenerative retinoschisis is a common condition defined by the splitting of the neurosensory retina that may rarely be associated with progressive retinal detachment (RD). Two patients (8%) experienced hypertony, that was well controlled with hypotonic drops. The absence of serous retinal detachment and the presence of hyperreflective foci at baseline were associated with a higher resistance and a poorer response to Ozurdex ®. and progression of epiretinal membrane after 25-gauge pars plana vitrectomy for rhegmatogenous retinal detachment. Significant differences in best-corrected visual acuity and central macular thickness were found between before Ozurdex ® injection and the last follow-up visit: from 0.57 ± 0.47 LogMAR to 0.34 ± 0.32 LogMAR (p = 0.02) and from 483.0 ± 124.0 µm to 354.6 ± 96.5 µm (p = 0.001), respectively. ERM formation after retinal reattachment surgery is. The retina is a thin layer of light-sensitive tissue at the back of your eyes. The multivariate analysis showed an increased risk of resistance in patients who underwent perfluorocarbon liquid (PFCL)-assisted drainage (adjusted odds ratio: 8.65 95% confidence interval: 1.97-15.33 p = 0.01). Summary Retinal tear surgery and retinal detachment surgery are distinct medical procedures. Twenty-five eyes (69.4%) were resistant to first-line therapy and received at least one Ozurdex ® injection (mean number: 2.7 ). The mean follow-up duration was 45.2 months (18.0-80.5 months). Of the 1152 patients screened, 36 eyes (3.1%) experienced POMO. Recent Findings Tractional retinal detachment is the leading cause of blindness in patients with diabetes. This was a retrospective, consecutive cohort study conducted in patients who underwent RRDR between January 2014 and December 2020 in the Rothschild Foundation Hospital and experienced postoperative MO (POMO) with a follow-up of at least 18 months. Purpose of Review To review the diagnosis, surgical evaluation, surgical techniques, and outcomes of vitrectomy for tractional retinal detachments (TRDs) in patients with diabetes. To assess the risk factors for resistance to first-line therapy and long-term response to dexamethasone intravitreal implant (Ozurdex ®) of patients with macular oedema (MO) secondary to rhegmatogenous retinal detachment repair (RRDR).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |